Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when WGRX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: WGRX DataMeds AI, Inc. 8-K

Wellgistics Health reports Q1 2026 financial results

Filed May 19, 2026 · Period ending May 19, 2026 · ~1 min read

2 key changes 3 sections

Key Changes

  • medium

    Company issued press release disclosing financial results for quarter ended March 31, 2026. Full details provided in attached exhibit.

  • low

    Press release furnished under Regulation FD but not formally 'filed' with SEC, meaning it won't be incorporated into other regulatory filings.

Summary

Wellgistics Health announced its first quarter 2026 financial results through a press release on May 19, 2026. The 8-K filing references the full earnings details in an attached exhibit, though the filing itself doesn't provide specific revenue, profit, or operational metrics. This is a standard quarterly earnings disclosure.

Retail investors should review the attached press release (Exhibit 99.1) for actual financial performance data, including revenue, earnings per share, and any forward guidance management provided. The company used Item 7.01 for the disclosure, which means the information is furnished rather than filed—a technical distinction that limits its use in future SEC filings but doesn't diminish its importance for understanding the company's current performance. Watch for the upcoming 10-Q filing, which will provide audited financials and management discussion that gives fuller context to these results.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~76 words

Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.

1 Added
Added Q1 2026 earnings medium

Added in current filing · verify on EDGAR →

On May 19, 2026, Wellgistics Health, Inc. (the “Company”) issued a press release setting forth the financial results for the quarter ended March 31, 2026.

The company disclosed its financial results for the quarter ended March 31, 2026 through a press release. The 8-K references Exhibit 99.1 containing the full press release with detailed financial information.

Event · Item 7.01 — Regulation FD Disclosure

~600 words

Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.

1 Added
Show 1 minor / wording change
Added Press release disclosure low

Added in current filing · verify on EDGAR →

On May 19, 2026, the Company issued a press release, a copy of which is furnished as Exhibit 99.1 hereto.

The company issued a press release on May 19, 2026, which is furnished as an exhibit under Regulation FD. The 8-K explicitly states this information is not deemed 'filed' for SEC purposes and will not be incorporated by reference into other filings. The actual content of the press release is not disclosed in the 8-K body itself.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Wellgistics Health filed an 8-K attaching a press release dated May 19, 2026; no material event details disclosed in the filing body.

1 Added
Added Press release attachment medium

Added in current filing · verify on EDGAR →

Press Release of Wellgistics Health, Inc., dated May 19, 2026

The 8-K references an attached press release dated May 19, 2026, but the filing body provides no details about the content or nature of the announcement. Without the exhibit text, the materiality and investor impact cannot be assessed.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 26, 2026 · How we verify